Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Increasing usage of novel genomics techniques and tools, evaluation of their benefit to patient outcome and focusing on steps to implement it and rising genome profiling technologies are expected to grow the genomics market at the rapid speed." The global Genomics Market is propelled by the introduction of novel technologies that utilize genomic information in disease research. It helps researchers comprehend the genetic bases of drug responses & diseases. Favorable government reimbursement policies coupled with high incidence of lifestyle diseases, such as diabetes & cancer and are key industry drivers. Popularity of genome profiling technologies and widespread use of innovative genomics tools & techniques can fuel market demand over the forecast period (2016-2024). Genomics is that aspect of biology that deals with bioinformatics, DNA, and DNA sequencing to analyze, assemble, and sequence the structure & function of genomes. Genomes refer to the entire DNA set in a single cell of an organism. The worldwide Genomics Market is systematically categorized on the basis of products, applications, technologies, and regions. Instruments, services, and consumables are the three key product segments. With a nearly 60% share, consumables dominated the industry in 2013. This segment is expected to grow at a CAGR surpassing 11% during the forecast period. Popularity of genomic testing in a host of commercial applications is a key driver of this segment. Browse Details of Report @ https://www.hexaresearch.com/research-report/genomics-industry
On the basis of applications, the global genomics industry is divided into academic research, drug discovery, diagnostics, personalized medicine, and others. Diagnostics held the highest market share in 2013. Preference for molecular diagnostics tests and awareness among medical practitioners about the advantages of geneticbased diagnostics are factors that propel this segment. It is expected that personalized medicine will register a high growth rate throughout the forecast period. Treatment optimization, affordable treatments, patient compliance, early disease prognosis, and drug safety are vital drivers of this segment. North America emerged a global leader in the market for personalized medicine in 2013. This was due to progress in the world of genetics and robust technological developments. As per technologies, the industry is segmented as DNA microarray, nucleic acid extraction & purification, PC R (polymerase chain reaction), and DNA sequencing. PCR led the market in 2013 due to factors, such as R&D in genomics & proteomics, encouraging government policies on R&D funding, and technological advancements. Ongoing industry trends suggest that the nucleic acid extraction & purification segment may grow at a CAGR exceeding 10% till 2024. Europe, Asia Pacific, North America, and Rest of the World are the four regional segments of the global Genomics Industry. Prevalence of cardiovascular & genetic disorders and high investments in genomics & proteomics drive the Europe genomics market. This region held the largest industry share in 2013. However, volatile economic conditions and uneven reimbursement policies may hamper regional growth in the forthcoming years. Asia Pacific is expected to grow rapidly over the forecast period because of widespread adoption of genomics techniques in emerging countries, such as China and India. These regions utilize genomics technologies to diagnose & treat diseases, like cancer and diabetes. Other factors that fuel the Asia Pacific region are surging medical expenditure, high disposable incomes, and better healthcare infrastructure. Key players in the global genomics market are Life Technologies, Roche Diagnostics, GE Healthcare, Agilent Technologies, and Cepheid. Researchers have developed a microscope that uses a cell phone camera for detecting fluorescent components of DNA sequencing responses in tissues & cells. This special device can identify point mutations in KRAS genes. The KRAS gene is found in more than thirty percent of colon cancers. A number of sequencing techniques are used to fluorescently label & amplify copies of the target DNA transcript or sequence. Browse Related Category Market Reports @ https://www.hexaresearch.com/researchcategory/biotechnology-industry
Table of Content of Genomics Market Table of Contents Chapter 1. Executive Summary 1.1. Genomics - Industry Summary and Critical Success Factors (CSFs) Chapter 2. Genomics Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Genomics - Market dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.3.3. Key Opportunities Prioritized 2.3.4. Genomics - PESTEL Analysis Chapter 3. Genomics Market Product Outlook 3.1. Genomics Market Revenue Share by Product, 2016 & 2024 3.2. Genomics Instruments Market 3.2.1. Genomics Instruments Market, 2016-2024 (USD Million) 3.2.1.1. Genomics Instruments Market, By Region 2016-2024 (USD Million) 3.3. Genomics Consumables Market 3.3.1. Genomics Consumables Market, 2016-2024 (USD Million) 3.3.1.1. Genomics Consumables Market, By Region 2016-2024 (USD Million) 3.4. Genomics Services Market 3.4.1. Genomics Services Market, 2016-2024 (USD Million) 3.4.1.1. Genomics Services Market, By Region 2016-2024 (USD Million) Chapter 4. Genomics Market Application Outlook 4.1. Genomics Market for Diagnostics 4.1.1. Genomics Market for Diagnostics 2016-2024 (USD Million) 4.1.1.1. Genomics Market for Diagnostics, By Region 2016-2024 (USD Million) 4.2. Genomics Market for Personalized Medicine 4.2.1. Genomics Market for Personalized Medicine, 2016-2024 (USD Million) 4.2.1.1. Genomics Market for Personalized Medicine, By Region 2016-2024 (USD Million)
4.3. Genomics Market for Drug Discovery and Development 4.3.1. Genomics Market for Drug Discovery and Development 2016-2024 (USD Million) 4.3.1.1. Genomics Market for Drug Discovery, By Region 2016-2024 (USD Million) 4.4. Genomics Market for Academic Research 4.4.1. Genomics Market for Academic Research, 2016-2024 (USD Million) 4.4.1.1. Genomics Market for Academic Research, By Region 2016-2024 (USD Million) 4.5. Genomics Market for Agriculture 4.5.1. Genomics Market for Agriculture, 2016-2024 (USD Million) 4.5.1.1. Genomics Market for Agriculture, By Region 2016-2024 (USD Million) Chapter 5. Small Interference RNA Market 5.1. sirna Market Revenue Share, 2016-2024 5.2. sirna Market, 2016-2024 (USD Million) Chapter 6. Genomics Market Technology Outlook 6.1. Genomics Market Revenue Share by Technology, 2016 & 2024 6.2. PCR Based Genomics Market 6.2.1. PCR Based Genomics Market, 2016-2024 (USD Million) 6.2.1.1. PCR Based Genomics Market, By Region 2016-2024 (USD Million) 6.3. DNA Sequencing Based Genomics Market 6.3.1. DNA Sequencing Based Genomics Market, 2016-2024 (USD Million) 6.3.1.1. DNA Sequencing Based Genomics Market, By Region 2016-2024 (USD Million) 6.4. DNA Microarray Based Genomics Market 6.4.1. DNA Microarray Based Genomics Market, 2016-2024 (USD Million) 6.4.1.1. DNA Microarray Based Genomics Market, By Region 2016-2024 (USD Million) 6.5. Nucleic Acid Extraction and Purification Based Genomics Market 6.5.1. Nucleic Acid Extraction and Purification Market, 2016-2024 (USD Million) 6.5.1.1. Nucleic Acid Extraction and Purification Market, By Region 2016-2024 (USD Million) Chapter 7. Genomics Market Regional Outlook 7.1. Genomics Market Revenue Share by Region, 2016 & 2024 7.2. North America Genomics Market 7.2.1. North America Genomics Market, 2016-2024 (USD Million) 7.3. Europe Genomics Market 7.3.1. Europe Genomics Market, 2016-2024 (USD Million) 7.4. Asia Pacific Genomics Market
7.4.1. Asia Pacific Genomics Market, 2016-2024 (USD Million) 7.5. RoW Genomics Market 7.5.1. RoW Genomics Market, 2016-2024 (USD Million) Chapter 8. Competitive Landscape 8.1. Affymetrix, Inc. 8.1.1. Company Overview 8.1.2. Financial Performance 8.1.3. Product Benchmarking 8.1.4. Strategic Initiatives 8.2. Agilent Technologies 8.2.1. Company Overview 8.2.2. Financial Performance 8.2.3. Product Benchmarking 8.2.4. Strategic Initiatives 8.3. BGI 8.3.1. Company Overview 8.3.2. Financial Performance 8.3.3. Product Benchmarking 8.3.4. Strategic Initiatives 8.4. Bio-Rad Laboratories Inc. 8.4.1. Company Overview 8.4.2. Financial Performance 8.4.3. Product Benchmarking 8.4.4. Strategic Initiatives 8.5. GE Healthcare 8.5.1. Company Overview 8.5.2. Financial Performance 8.5.3. Product Benchmarking 8.5.4. Strategic Initiatives 8.6. Illumina Inc. 8.6.1. Company Overview 8.6.2. Financial Performance 8.6.3. Product Benchmarking 8.6.4. Strategic Initiatives 8.7. Qiagen
8.7.1. Company Overview 8.7.2. Financial Performance 8.7.3. Product Benchmarking 8.7.4. Strategic Initiatives 8.8 Roche Diagnostics 8.8.1. Company Overview 8.8.2. Financial Performance 8.8.3. Product Benchmarking 8.8.4. Strategic Initiatives 8.9. Life Technologies 8.9.1. Company Overview 8.9.2. Product Benchmarking 8.9.3. Strategic Initiatives 8.10. Cepheid 8.10.1. Company Overview 8.10.2. Financial Performance 8.10.3. Product Benchmarking 8.10.4. Strategic Initiatives Chapter 9. Methodology and Scope 9.1. Research Methodology 9.2. Research Scope & Assumptions 9.3. List of Data Sources
About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: hexaresearch1.blogspot.com